These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761 [TBL] [Abstract][Full Text] [Related]
25. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370 [TBL] [Abstract][Full Text] [Related]
26. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Mannelli M; Castellano M; Schiavi F; Filetti S; Giacchè M; Mori L; Pignataro V; Bernini G; Giachè V; Bacca A; Biondi B; Corona G; Di Trapani G; Grossrubatscher E; Reimondo G; Arnaldi G; Giacchetti G; Veglio F; Loli P; Colao A; Ambrosio MR; Terzolo M; Letizia C; Ercolino T; Opocher G; J Clin Endocrinol Metab; 2009 May; 94(5):1541-7. PubMed ID: 19223516 [TBL] [Abstract][Full Text] [Related]
27. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study. Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378 [TBL] [Abstract][Full Text] [Related]
29. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas. Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360 [TBL] [Abstract][Full Text] [Related]
31. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297 [TBL] [Abstract][Full Text] [Related]
32. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP; JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420 [TBL] [Abstract][Full Text] [Related]
33. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas]. Taschner PE; Bröcker-Vriends AH; van der Mey AG Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography. Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839 [TBL] [Abstract][Full Text] [Related]
35. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730 [TBL] [Abstract][Full Text] [Related]
37. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice. Saie C; Buffet A; Abeillon J; Drui D; Leboulleux S; Bertherat J; Zenaty D; Storey C; Borson-Chazot F; Burnichon N; Vincent M; Favier J; Baudin E; Giraud S; Gimenez-Roqueplo AP; Amar L; Lussey-Lepoutre C J Clin Endocrinol Metab; 2021 Mar; 106(3):e1301-e1315. PubMed ID: 33247927 [TBL] [Abstract][Full Text] [Related]
38. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002 [TBL] [Abstract][Full Text] [Related]